Our offering

Our team

Diverse Expertise

Our team comes from backgrounds in equity research, market analysis, and consulting. We actively partner with talent from across Latin America.Our structure is flat, collaborative, and merit‑driven, giving every team member ownership of their work and direct impact on idea generation.We bring a perspective shaped by culture, discipline, and analytical rigor — a combination that drives our ability to see what others may overlook.

Regulatory Integrity

Our sales and client facing professionals translate complex research into clear, actionable value for institutional investors.We maintain a rigorous culture of compliance, as a firm authorised and regulated by the UK Financial Conduct Authority, we are committed to upholding the highest standards of integrity, accountability, and regulatory discipline in every aspect of our business.

RenkoEdge is authorised and regulated by the Financial Conduct Authority. Our FCA Firm Reference Number is: 1042412

FOR IMMEDIATE RELEASERenkoEdge Ltd Receives Direct FCA Authorisation, Expanding Its Independent Equity Research Platform for Institutional InvestorsLONDON, UK – May 7, 2026 – RenkoEdge Ltd, an independent equity research and advisory firm serving institutional investors, today announced that it has received direct authorisation from the UK Financial Conduct Authority (FCA) under Firm Reference Number (FRN) 1042412.The authorisation marks a significant milestone in the firm’s development, transitioning RenkoEdge from the Appointed Representative (AR) model to operating as a directly authorised FCA-regulated entity.The move strengthens the firm’s operational independence and regulatory infrastructure as it continues to expand its institutional research offering and advisory capabilities.Alex Olvera, Chief Executive Officer of RenkoEdge Ltd, commented:
"Obtaining direct authorisation from the FCA represents an important milestone for RenkoEdge. The Appointed Representative model served us well in our initial growth phase, but as our client base continues to increase, direct authorisation provides the independence and flexibility required to scale our research platform in line with the needs of institutional clients.Securing our own direct permissions removes third-party dependencies and allows us to implement a bespoke compliance framework tailored specifically to our unique methodologies”About RenkoEdge Ltd
RenkoEdge Ltd is an independent research and advisory firm focused on delivering differentiated equity research and market insights for institutional investors. The firm specialises in non-consensus research designed to help clients identify asymmetric opportunities, improve diversification, and enhance risk-adjusted returns.Media Contact:
RenkoEdge Ltd
Email: [email protected]
Phone: +44 (0)208 798 3597

Disclaimer & Regulatory StatusStatutory Disclosure: Renkoedge Ltd is authorised and regulated by the Financial Conduct Authority (FRN: 1042412).Professional Clients Only: The content provided by RenkoEdge is intended exclusively for Professional Clients and Eligible Counterparties. It is not intended for, and must not be relied upon by, Retail Clients.No Investment Advice: This site and the research produced by RenkoEdge are for informational purposes only. No information herein constitutes a solicitation, offer, or recommendation to buy or sell securities.Risk Warning: Investment in financial markets involves significant risk. Past performance is never a guarantee of future results. RenkoEdge accepts no liability for any loss arising from the use of the information contained on this site.Intellectual Property: All research and proprietary strategies are the property of RenkoEdge and may not be redistributed without express written consent.

Market Abuse PolicyThis policy establishes arrangements appropriate to the nature of our boutique research operations to prevent and detect market abuse.UK MAR Compliance: RenkoEdge adheres strictly to the UK Market Abuse Regulation (UK MAR) and the FCA’s Market Conduct sourcebook (MAR).Inside Information: Staff are strictly prohibited from researching, recommending, or trading—personally or for others—on the basis of Inside Information.Front-Running & Objectivity: As an independent research provider, Renkoedge prohibits staff from trading in financial instruments that are the subject of pending research publications until such research has been disseminated to Professional Clients.Banned List: The Compliance Officer maintains a Restricted List. Any security for which the firm is deemed to have non-public information is immediately blocked from all internal discussion and recommendation.Training: All staff undergo mandatory Market Abuse and Conduct training upon induction and annually thereafter.

Privacy PolicyRenkoEdge is committed to protecting your privacy. To minimize regulatory complexity and maximize security, RenkoEdge does not collect, store, or process personal data from visitors to our website.No Data Harvesting: We do not provide contact forms or newsletter sign-ups that capture user information.Limited Processing: We only process personal data when it is voluntarily provided to us (e.g., via direct email for professional inquiries). This information is used solely to respond to your request and is deleted once the interaction is complete, unless required for legal or FCA regulatory record-keeping.Third Parties: We do not share, sell, or trade any information with third parties.RenkoEdge operates as a data-exempt entity to the fullest extent permitted by the UK Data Protection Act 2018.For any inquiries regarding our data-light policy, contact [email protected].